Josep Domingo‐Domenech
- Cancer Research top 5%
- Cancer, Lipids, and Metabolism 4
- NF-κB Signaling Pathways 4
- Oncology top 5%
- Cancer Cells and Metastasis 10
-
- Prostate Cancer Treatment and Research 14
- Brain Metastases and Treatment 3
- Molecular Biology top 10%
- Epigenetics and DNA Methylation 6
-
- Bladder and Urothelial Cancer Treatments 5
- Urinary and Genital Oncology Studies 4
- Co-authors
- Carlos Cordon‐CardoVerónica Rodríguez-BravoMireia Castillo-MartínSamuel J. VidalOrit Karni-SchmidtMatt D. GalskyTulio MatosNataliya Gladoun
- Partner nations
- United StatesSpainFrance
In The Last Decade
Josep Domingo‐Domenech
45 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 84
- Cancer Research 599
- Oncology 885
- Pulmonary and Respiratory Medicine 593
- Molecular Biology 1.2k
- Immunology 215
Countries citing papers authored by Josep Domingo‐Domenech
This map shows the geographic impact of Josep Domingo‐Domenech's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Josep Domingo‐Domenech with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Josep Domingo‐Domenech more than expected).
Fields of papers citing papers by Josep Domingo‐Domenech
This network shows the impact of papers produced by Josep Domingo‐Domenech. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Josep Domingo‐Domenech. The network helps show where Josep Domingo‐Domenech may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Josep Domingo‐Domenech, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 4 | |
| 2 | 2021 | 46 | |
| 3 | 2020 | 32 | |
| 4 | 2020 | 70 | |
| 5 | 2019 | 1 | |
| 6 | 2018 | 216 | |
| 7 | 2017 | 10 | |
| 8 | 2015 | 160 | |
| 9 | 2014 | 5 | |
| 10 | 2013 | 25 | |
| 11 | 2013 | 215 | |
| 12 | 2012 | 338 | |
| 13 | 2011 | 105 | |
| 14 | 2010 | 191 | |
| 15 | 2007 | 34 | |
| 16 | 2007 | 18 | |
| 17 | 2006 | 88 | |
| 18 | 2006 | 6 | |
| 19 | 2005 | 101 | |
| 20 | 2004 | 15 |
About Josep Domingo‐Domenech
Josep Domingo‐Domenech is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 46 papers that have together received 2.1k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (14 papers), Cancer Cells and Metastasis (10 papers), Epigenetics and DNA Methylation (6 papers), Bladder and Urothelial Cancer Treatments (5 papers), Cancer, Lipids, and Metabolism (4 papers), Urinary and Genital Oncology Studies (4 papers), NF-κB Signaling Pathways (4 papers) and Brain Metastases and Treatment (3 papers). The work is most often cited by research in Cancer Research (599 citations), Oncology (885 citations) and Pulmonary and Respiratory Medicine (593 citations). Josep Domingo‐Domenech has collaborated with scholars based in United States, Spain and France. Frequent co-authors include Carlos Cordon‐Cardo, Verónica Rodríguez-Bravo, Mireia Castillo-Martín, Samuel J. Vidal, Orit Karni-Schmidt, Matt D. Galsky, Tulio Matos, Nataliya Gladoun, Matthew D. Galsky and Dennis M. Bonal. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.